Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV001149053 | SCV001309984 | uncertain significance | Epidermolysis bullosa dystrophica | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Invitae | RCV001858979 | SCV002201710 | likely benign | not provided | 2024-01-21 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002480546 | SCV002793860 | uncertain significance | Recessive dystrophic epidermolysis bullosa; Pretibial dystrophic epidermolysis bullosa; Dominant dystrophic epidermolysis bullosa with absence of skin; Transient bullous dermolysis of the newborn; Epidermolysis bullosa pruriginosa; Nonsyndromic congenital nail disorder 8; Generalized dominant dystrophic epidermolysis bullosa | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001280117 | SCV001467270 | uncertain significance | Epidermolysis bullosa dystrophica inversa, autosomal recessive | 2020-06-24 | no assertion criteria provided | clinical testing |